Form 4 for AVTX Avalo Therapeutics, Inc.
Accepted 2023-06-14 00:00:00 ET · period of report 2023-06-12 · accession 0001929354-23-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-06-14 | 2023-06-12+ | AVTX | Caissa Capital Management ltd. | 10% | P - Purchase | $3.77 | +16.9K | 1.41M | +1% | +$63.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-14 | P | A | 6,000 | $3.48 | 1,417,540 | I See Footnote (1) | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.245 to $3.55, inclusive. (F1) Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh. |
| 2 | Common | Common Stock | 2023-06-12 | P | A | 2,149 | $4.34 | 1,402,790 | I See Footnote (1) | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.125 to $4.47, inclusive. (F1) Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh. |
| 3 | Common | Common Stock | 2023-06-13 | P | A | 8,750 | $3.82 | 1,411,540 | I See Footnote (1) | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7 to $3.83, inclusive. (F1) Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh. |